Louisiana State Employees Retirement System’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $308K | Sell |
15,700
-500
| -3% | -$12.2K | 0.01% | 1465 |
|
|
2025
Q4 | $434K | Sell |
16,200
-300
| -2% | -$7.73K | 0.01% | 1390 |
|
|
2025
Q3 | $440K | Sell |
16,500
-700
| -4% | -$18.1K | 0.01% | 1377 |
|
|
2025
Q2 | $395K | Sell |
17,200
-500
| -3% | -$12.4K | 0.01% | 1392 |
|
|
2025
Q1 | $513K | Sell |
17,700
-400
| -2% | -$12.8K | 0.01% | 1312 |
|
|
2024
Q4 | $672K | Sell |
18,100
-300
| -2% | -$13.7K | 0.01% | 1226 |
|
|
2024
Q3 | $893K | Sell |
18,400
-800
| -4% | -$35.1K | 0.02% | 1094 |
|
|
2024
Q2 | $768K | Buy |
19,200
+700
| +4% | +$29K | 0.01% | 1137 |
|
|
2024
Q1 | $812K | Sell |
18,500
-200
| -1% | -$10.3K | 0.02% | 1128 |
|
|
2023
Q4 | $1.16M | Sell |
18,700
-700
| -4% | -$36.8K | 0.02% | 850 |
|
|
2023
Q3 | $892K | Sell |
19,400
-400
| -2% | -$21.8K | 0.02% | 956 |
|
|
2023
Q2 | $1.14M | Buy |
19,800
+2,200
| +13% | +$97.5K | 0.03% | 792 |
|
|
2023
Q1 | $660K | Sell |
17,600
-300
| -2% | -$9.84K | 0.02% | 1112 |
|
|
2022
Q4 | $502K | Sell |
17,900
-400
| -2% | -$11.6K | 0.01% | 1234 |
|
|
2022
Q3 | $514K | Buy |
18,300
+100
| +0.5% | +$3.27K | 0.02% | 1176 |
|
|
2022
Q2 | $667K | Buy |
18,200
+300
| +2% | +$10.7K | 0.02% | 1091 |
|
|
2022
Q1 | $700K | Buy |
17,900
+100
| +0.6% | +$2.84K | 0.02% | 1143 |
|
|
2021
Q4 | $415K | Hold |
17,800
| – | – | 0.01% | 1376 |
|
|
2021
Q3 | $338K | Buy |
17,800
+1,300
| +8% | +$25.5K | 0.01% | 1422 |
|
|
2021
Q2 | $333K | Sell |
16,500
-100
| -0.6% | -$1.88K | 0.01% | 1417 |
|
|
2021
Q1 | $304K | Sell |
16,600
-200
| -1% | -$3.72K | 0.01% | 1429 |
|
|
2020
Q4 | $338K | Sell |
16,800
-100
| -0.6% | -$1.95K | 0.01% | 1337 |
|
|
2020
Q3 | $317K | Buy |
16,900
+7,780
| +85% | +$157K | 0.01% | 1213 |
|
|
2020
Q2 | $205K | Buy |
+9,120
| New | +$167K | 0.01% | 1217 |
|
|
2020
Q1 | – | Sell |
-11,680
| Closed | -$225K | – | 1296 |
|
|
2019
Q4 | $225K | Sell |
11,680
-1,020
| -8% | -$19.6K | 0.01% | 1336 |
|
|
2019
Q3 | $252K | Sell |
12,700
-500
| -4% | -$10.4K | 0.01% | 1298 |
|
|
2019
Q2 | $267K | Buy |
13,200
+300
| +2% | +$6.27K | 0.01% | 1283 |
|
|
2019
Q1 | $264K | Sell |
12,900
-41
| -0.3% | -$919 | 0.01% | 1303 |
|
|
2018
Q4 | $258K | Sell |
12,941
-2,359
| -15% | -$46.5K | 0.01% | 1269 |
|
|
2018
Q3 | $294K | Sell |
15,300
-800
| -5% | -$14.3K | 0.01% | 1363 |
|
|
2018
Q2 | $246K | Buy |
16,100
+400
| +3% | +$6.99K | 0.01% | 1412 |
|
|
2018
Q1 | $294K | Buy |
15,700
+500
| +3% | +$9.4K | 0.01% | 1335 |
|
|
2017
Q4 | $292K | Buy |
15,200
+800
| +6% | +$14.9K | 0.01% | 1334 |
|
|
2017
Q3 | $257K | Sell |
14,400
-100
| -0.7% | -$1.65K | 0.01% | 1345 |
|
|
2017
Q2 | $259K | Sell |
14,500
-100
| -0.7% | -$1.59K | 0.01% | 1336 |
|
|
2017
Q1 | $212K | Buy |
14,600
+200
| +1% | +$3.15K | 0.01% | 1384 |
|
|
2016
Q4 | $265K | Sell |
14,400
-1,200
| -8% | -$23.3K | 0.01% | 1324 |
|
|
2016
Q3 | $296K | Buy |
+15,600
| New | +$283K | 0.02% | 1278 |
|
Other funds holding AMPH
VCM
BTW
Louisiana State Employees Retirement System's AMPH Position: Q1 2026 in Review
Louisiana State Employees Retirement System reduced its Amphastar Pharmaceuticals (AMPH) stake by 3.1% in Q1 2026, selling an estimated $12.2K and leaving 15,700 shares worth $308K. The position accounts for 0.01% of the portfolio, ranked #1465.
Louisiana State Employees Retirement System first reported a position in AMPH in Q3 2016 and has held it in 38 quarters since. The position peaked at $1.16M in Q4 2023. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.
- Louisiana State Employees Retirement System held 15,700 shares of Amphastar Pharmaceuticals worth $308K as of Q1 2026.
- Louisiana State Employees Retirement System sold 500 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $12.2K.
- Amphastar Pharmaceuticals made up 0.01% of Louisiana State Employees Retirement System's portfolio in Q1 2026, its #1465 holding.
- Louisiana State Employees Retirement System first reported a position in Amphastar Pharmaceuticals in Q3 2016 and has held it in 38 quarters since.
- Louisiana State Employees Retirement System's Amphastar Pharmaceuticals position peaked at $1.16M in Q4 2023.
- 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.
Based on Louisiana State Employees Retirement System's 13F filing for Q1 2026, filed 20 Apr 2026.